Modified RNA creates stable therapeutic nanoparticles

But by replacing a chemical group in the macromolecule, Dr. Guo says he and fellow researchers have found a way to bypass RNase and create stable three-dimensional configurations of RNA, greatly expanding the possibilities for RNA in nanotechnology. Dr. Guo and his colleagues published their findings in the journal ACS Nano. Dr. Guo is the co-principal investigator of the Cancer Nanotechnology Platform Partnership at the University of Cincinnati, one of 12 such partnerships funded by the National Cancer Institute.

In their work, Dr. Guo and his colleagues focused on the ribose rings that, together with alternating phosphate groups, form the backbone of RNA. By changing one section of the ribose ring, Dr. Guo and his team altered the structure of the molecule, making it unable to bind with RNase and able to resist degradation. "RNase interaction with RNA requires a match of structural conformation," he explained. "When RNA conformation has changed, the RNase cannot recognize RNA and the binding becomes an issue." While previous researchers have shown this alteration makes RNA stable in a double helix, Dr. Guo says that they did not study its potential to affect the folding of RNA into a three-dimensional structure necessary for nanotechnology.

After creating the RNA nanoparticle, Guo and his colleagues successfully used it to power the DNA packaging nanomotor of bacteriophage phi29, a virus that infects bacteria. "We found that the modified RNA can fold into its 3-D structure appropriately, and can carry out its biological functions after modification," says Guo. "Our results demonstrate that it is practical to produce RNase-resistant, biologically active, and stable RNA for application in nanotechnology."

Because stable RNA molecules can be used to assemble a variety of nanostructures, Guo says they are an ideal tool to deliver targeted therapies to cancerous or viral-infected cells. "RNA nanoparticles can be fabricated with a level of simplicity characteristic of DNA while possessing versatile structure and catalytic function similar to that of proteins. With this RNA modification, hopefully we can open new avenues of study in RNA nanotechnology."

This work, which is detailed in a paper titled, "Fabrication of Stable and RNasae-Resistant RNA Nanoparticles Active in Gearing the Nanomotors for Viral DNA Packaging Engineering of Self-Assembled Nanoparticle Platform for Precisely Controlled Combination Drug Therapy," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. An abstract of this paper is available at the journal's website.

Provided by National Cancer Institute